Abstract

After nephron-sparing surgery (NSS), postsurgical fatty tumor could be mistakenly reported as angiomyolipoma during radiologic imaging of some patients. In the present paper, we studied the postsurgical fatty tumor detected after NSS but not covered before in the literature. In addition, we also evaluated whether the postsurgical fatty tumor was related to the surgical technique employed. Patients admitted to the urology department of our university hospital from 2014 to 2019 and operated with open NSS were evaluated retrospectively. We detected those 156 patients were operated with NSS. Nine patients with angiomyolipoma as primary pathology and four patients with surgical border positivity were excluded from the study. The patients were divided into two groups based on the repair of tumor extraction region. In Group 1, fatty tissue was used for repair, and Group 2 is the primary repair group. In all, 143 patients (Group 1 = 79, and Group 2 = 64) were included in the study. No demographic and radiologic differences, such as number of patients, age, gender, positioning of tumor, mass localization, tumor diameter, and RENAL nephrometry scoring system, were detected between the two groups. Postsurgical fatty tumors were detected in 28 patients in Group 1 and in two patients in Group 2 (P < 0.001). In patients with negative surgical margins after partial nephrectomy, lesions that were radiologically detected mimicking as angiomyolipoma were defined as “postsurgical fatty tumor.” This mass containing adipose tissue only neither depicted vascularization and enhancement nor increase in size for at least 1 year. We assumed that these lesions must be followed as benign lesions not requiring additional treatment.

Highlights

  • Renal cell carcinomas (RCC) constitute 90–95% of the masses detected in the kidneys

  • Partial nephrectomy was applied after retrospective data scanning in 143 patients

  • Postsurgical fatty tumor in Group 1 was detected in 28 patients (35.4%), in which fat tissue was used for repair

Read more

Summary

Introduction

RCCs are the third most common malignancy among urogenital tumors [1]. Their prevalence has increased in Europe as well as globally in the last 20 years. Journal of Kidney Cancer and VHL 2022; 9(1): 1–8 were treated with radical nephrectomy in the past, presently, partial nephrectomy has become the first option for treating renal masses. This technique was applied only in treating renal masses measuring less than 4 cm; nephron-sparing surgery (NSS) is used even in case of renal masses measuring more than 7 cm [3,4,5]. The main principle is to remove the mass altogether, leaving the maximal capacity of normal parenchymal tissues without any remaining tumoral tissues [7,8,9,10]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.